Produkty 190085-41-7

CAS 190085-41-7 występuje w naszej ofercie pod nazwami: Butyloctyl salicylate, 95%+, 2-Butyloctyl 2-hydroxybenzoate, 95%, Benzoic acid, 2-hydroxy-, 2-butyloctyl ester, 98%. Oferty producentów: Chemat, BLDpharm, Fluorochem. Dostępne opakowania: 100mg, 250mg, 1g, 5g, 10g, 25g.

Butyloctyl salicylate, 95%+
Chemat
  • opakowanie: 100mg, 250mg, 1g, 5g
  • Warianty: 6
od 146,00
Zobacz produkt
2-Butyloctyl 2-hydroxybenzoate, 95%
BLDpharm
  • opakowanie: 250mg, 1g, 5g, 10g
  • Warianty: 5
od 236,61
Zobacz produkt
Benzoic acid, 2-hydroxy-, 2-butyloctyl ester, 98%
Fluorochem
  • opakowanie: 250mg, 1g, 5g
  • Warianty: 3
od 289,50
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

2-butyloctyl 2-hydroxybenzoate (CAS 190085-41-7) to związek chemiczny o wzorze sumarycznym C19H30O3 i masie molowej 306.4 g/mol. Nazwa systematyczna IUPAC: 2-butyloctyl 2-hydroxybenzoate. InChIKey: CZVOIAOPRGNENY-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H30O3
Masa molowa306.4 g/mol
Nazwa IUPAC2-butyloctyl 2-hydroxybenzoate
InChIKeyCZVOIAOPRGNENY-UHFFFAOYSA-N
SMILESCCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O

Dane obliczone przez PubChem (NCBI)

Synonimy: Butyloctyl salicylate, Benzoic acid, 2-hydroxy-, 2-butyloctyl ester, Hallbrite BHB, 2-butyloctyl o-hydroxybenzoate, BUTYLOCTYL SALICYLATE [INCI], 2-hydroxybenzoic acid 2-butyloctyl ester, Butyl octanol salicylate ester, CZVOIAOPRGNENY-UHFFFAOYSA-N
Izomery (ten sam wzór sumaryczny)
dodecyl 2-hydroxybenzoate C19H30O3
dodecyl 4-hydroxybenzoate C19H30O3
ethyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate C19H30O3
(3R,5S,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(1S,3aS,3bR,5aR,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one C19H30O3
(4R,6R)-6-[2-[(1S,2S,4aR,6R,8aS)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethyl]-4-hydroxyoxan-2-one C19H30O3
(1S,3aS,3bR,5aS,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one C19H30O3
(3S,4S,5R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one C19H30O3
(4aS,4bR,6aR,10aS,10bS,12aS)-8-hydroxy-10a,12a-dimethyl-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydronaphtho[2,1-f]chromen-2-one C19H30O3
(3R,5R,8R,9S,10S,13S,14S,16R)-3,16-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(3R,5R,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3